Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Otsuka describes new analgesics

Dec. 24, 1996

Natural antineoplastic agents described by Fujisawa

Dec. 24, 1996

Bin1 described by Wistar Institute for cancer Rx and Dx

Dec. 24, 1996

Connaught describes potential acellular pertussis vaccines

Dec. 24, 1996

Neuroprotective polypeptide reported by Amgen

Dec. 24, 1996

Fujisawa discloses antiplatelet agents

Dec. 24, 1996

Agents for urinary incontinence reported by Dainippon

Dec. 23, 1996

LHRH antagonists under study at Takeda

Dec. 23, 1996

Boehringer Ingelheim's modified anti-ICAM-1 antibodies for inflammatory disorders

Dec. 23, 1996

New antiplatelet drugs from Takeda

Dec. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...